The government alleged Millennium systematically billed federal healthcare programs for excessive and unnecessary urine drug testing from Jan. 1, 2008, through May 20, 2015. The government claimed Millennium caused physicians to order excessive numbers of urine drug tests through the promotion of “custom profiles,” which led physicians to order a large number tests without an individualized assessment of each patient’s needs.
The government further alleged Millennium submitted false claims to Medicare and Medicaid from Jan. 1, 2012, through May 20, 2015, for genetic testing that was performed routinely and without an individualized assessment of each patient’s needs.
Under the agreement, Millennium will pay $237 million to resolve the false claims allegations. The company also agreed to pay CMS $19.2 million to resolve certain administrative actions related to its urine drug testing billing practices, according to the DOJ.
Although Millennium has agreed to this settlement, there has been no determination of liability in the case.
More articles on healthcare industry lawsuits:
9 latest healthcare industry lawsuits, settlements
Tuomey dodges $237M false claims verdict by settling with DOJ: 10 things to know
The ‘halo over nonprofits’ is gone and 3 other takeaways from recent Stark Law settlements
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
